Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status.

Ilona DudkaElin ThysellKristina LundquistHenrik AnttiDiego Iglesias-GatoAmilcar Flores-MoralesAnders BerghPernilla WikströmGerhard Gröbner

Published in: BMC cancer (2020)

Our comprehensive metabolomic analysis strongly indicates that ERG-positive PC and ERG-negative PC should be considered as different subtypes of PC; a fact requiring different, sub-type specific treatment strategies for affected patients.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
mass spectrometry
radical prostatectomy
peritoneal dialysis